Skip to content
Serodus
  • About Serodus
    • Board of directors
    • Management
    • Former Advisors
  • Pipeline
    • SER150
    • SER140
    • Diabetic Kidney Disease
  • OPEN FOR ACQUISITION
  • Investor
    • Financial Calendar
    • Quarterly Reports
    • Annual Reports
    • General Meeting
    • Article of Association
    • Corporate governance
  • News
  • Contact
  • Toggle website search
Menu Close

2025-04 – Q1 2025 Reporting

  • Post author:Henrik Mordhorst
  • Post published:30-04-2025
  • Post category:News

Draft report SER150 CL-009 was received and will be discussed with the Australian contract organisation and the Serodus biostatistician consultant. In March 2025 the company launched a Private Placement with…

Continue Reading2025-04 – Q1 2025 Reporting

2025-03 – Serodus AS – Subsequent Offering 2025

  • Post author:Henrik Mordhorst
  • Post published:20-03-2025
  • Post category:News

Download investor letter here

Continue Reading2025-03 – Serodus AS – Subsequent Offering 2025

2025-03 – Serodus AS – Minutes of Annual General Meeting 2025

  • Post author:Henrik Mordhorst
  • Post published:20-03-2025
  • Post category:News

Download the minutes here

Continue Reading2025-03 – Serodus AS – Minutes of Annual General Meeting 2025

2025-03 – 2024 Annual Report

  • Post author:seroadmin
  • Post published:10-03-2025
  • Post category:News

Serodus AS - Publishes 2024 Annual Report Download it here

Continue Reading2025-03 – 2024 Annual Report

2025-03 – Serodus AS – Notice of General Meeting 2025

  • Post author:Henrik Mordhorst
  • Post published:06-03-2025
  • Post category:News

Download notice here

Continue Reading2025-03 – Serodus AS – Notice of General Meeting 2025

2024-10 – Q3 2024 Reporting

  • Post author:Henrik Mordhorst
  • Post published:31-10-2024
  • Post category:News

Unblinding of the database after SER150 CL-009 was delayed. Calculation of SER150 effect on kidney function compared to placebo is consequently also delayed. Read more here

Continue Reading2024-10 – Q3 2024 Reporting

2024-08 – Q2 2024 Reporting

  • Post author:Henrik Mordhorst
  • Post published:14-08-2024
  • Post category:News

Contacts to banks for assisting Serodus in selling Serodus AS, the pipeline or the individual assets was initiated. Database for SER150 CL-009 is expected to be unblinded late August or…

Continue Reading2024-08 – Q2 2024 Reporting

2024-06 – Serodus AS – Minutes of Annual General Meeting 2024

  • Post author:Henrik Mordhorst
  • Post published:28-06-2024
  • Post category:News

Download the minutes here

Continue Reading2024-06 – Serodus AS – Minutes of Annual General Meeting 2024

2024-05 – Serodus ASA – Notice of General Meeting 2024

  • Post author:Henrik Mordhorst
  • Post published:31-05-2024
  • Post category:News

Read more here

Continue Reading2024-05 – Serodus ASA – Notice of General Meeting 2024

2024-05 – 2023 Annual Report

  • Post author:Henrik Mordhorst
  • Post published:31-05-2024
  • Post category:News

Serodus ASA - Publishes 2023 Annual Report Download it here

Continue Reading2024-05 – 2023 Annual Report
  • 1
  • 2
  • 3
  • 4
  • Go to the next page

Serodus AS

Heia 8
N-0268 Oslo
Norway

Contact us

News

Sign up below to receive our newsletters.
Close Menu
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT